Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy.

Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy.

Item
http://www.wikidata.org/entity/Q34613360
EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potentialOptimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination.Recent advances in understanding and managing leiomyosarcomasOverall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma.Curative resection for leiomyosarcoma of the descending mesocolon with metachronous liver metastasis: A case report and literature review.Clinical Observations and Molecular Variables of Primary Vascular LeiomyosarcomaSoft tissue sarcomas, a look into the future: different treatments for different subtypes.The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma.Metastatic mesenteric dedifferentiated leiomyosarcoma: a case report and a review of literatureSynchronous coexistence of liver metastases from cecal leiomyosarcoma and rectal adenocarcinoma: A case report.Extensively Metastasizing Leiomyosarcoma: A Diagnostic Challenge.Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors.Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies.Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcomeRandomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma G
P2860

Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy.

Item
http://www.wikidata.org/entity/Q34613360
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Factors affecting the outcome ...... bicin-containing chemotherapy.
@ast
Factors affecting the outcome ...... bicin-containing chemotherapy.
@en
Factors affecting the outcome ...... bicin-containing chemotherapy.
@nl
type
label
Factors affecting the outcome ...... bicin-containing chemotherapy.
@ast
Factors affecting the outcome ...... bicin-containing chemotherapy.
@en
Factors affecting the outcome ...... bicin-containing chemotherapy.
@nl
prefLabel
Factors affecting the outcome ...... bicin-containing chemotherapy.
@ast
Factors affecting the outcome ...... bicin-containing chemotherapy.
@en
Factors affecting the outcome ...... bicin-containing chemotherapy.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Factors affecting the outcome ...... bicin-containing chemotherapy.
@en
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P921